Clinical manifestations of different viral respiratory infections in athletes: implications for risk assessment and return-to-sport - AWARE VII study in 116 cases.
{"title":"Clinical manifestations of different viral respiratory infections in athletes: implications for risk assessment and return-to-sport - AWARE VII study in 116 cases.","authors":"Marcel Jooste, Nicola Sewry, Maarit Valtonen, Marlise Dyer, Esme Jordaan, Martin Schwellnus","doi":"10.1080/00913847.2025.2518748","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The aims of this study were to describe the etiology of acute respiratory infections (ARinf) in athletic individuals, and to identify differences in the clinical presentation, evidence of possible multi-organ involvement, and illness classification between common pathogen groups.</p><p><strong>Methods: </strong>One-hundred-and-sixteen cases of confirmed ARinf in athletic individuals were evaluated ≤ 5 days of the onset of an ARinf. Nasopharyngeal swab multiplex PCR testing was performed to identify a causative pathogen. Symptomatology, clinical examination findings, results of selected blood tests, and the clinical syndrome and illness severity classifications were compared between four common pathogen groups.</p><p><strong>Results: </strong>The etiologies of ARinf in this cohort were: rhinovirus = 34(29%), influenza = 17(15%), SARS-CoV-2 = 15(13%), common coronavirus = 13(11%), 'unidentified' = 16(14%), 'dual pathogen' = 9(8%), and 'other' = 12(10%). Clinical presentation differed among the four common pathogen groups as follows: Influenza had more <i>total symptoms</i>, <i>lower respiratory & regional</i> symptoms, and <i>systemic & non-respiratory</i> symptoms than rhinovirus (<i>p</i> ≤ 0.002) and common coronavirus (<i>p</i> < 0.05). Influenza and SARS-CoV-2 had higher <i>total symptoms</i> and <i>systemic & non-respiratory</i> symptom severity scores than rhinovirus (<i>p</i> ≤ 0.0006 and <i>p</i> < 0.03 respectively) and common coronavirus (<i>p</i> ≤ 0.03 and <i>p</i> = 0.02 respectively). Evidence of <i>other non-respiratory organ involvement</i> on clinical examination was highest for influenza (53%). Illness classification for pathogen groups differed: common coronavirus had the highest percentage (%) of <i>rhinitis-like ('common cold')</i> illnesses (69%), and influenza had the highest % of '<i>flu-like'</i> illnesses (82%). Influenza had the highest % of <i>severe</i> illnesses (88%) and common coronavirus the lowest (31%). 41% of rhinovirus presented with severe illness.</p><p><strong>Conclusion: </strong>Influenza and SARS-CoV-2 had greater number and severity of symptoms than rhinovirus and common coronavirus. Among the four common pathogen groups, influenza had the highest percentage of abnormal clinical examination and serological findings and severe illnesses. Knowledge of the causative pathogen and the clinical presentation may add value to the risk assessment and guide clinical decision-making in return-to-sport following ARinf in athletic individuals.</p>","PeriodicalId":51268,"journal":{"name":"Physician and Sportsmedicine","volume":" ","pages":"1-10"},"PeriodicalIF":1.9000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physician and Sportsmedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00913847.2025.2518748","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: The aims of this study were to describe the etiology of acute respiratory infections (ARinf) in athletic individuals, and to identify differences in the clinical presentation, evidence of possible multi-organ involvement, and illness classification between common pathogen groups.
Methods: One-hundred-and-sixteen cases of confirmed ARinf in athletic individuals were evaluated ≤ 5 days of the onset of an ARinf. Nasopharyngeal swab multiplex PCR testing was performed to identify a causative pathogen. Symptomatology, clinical examination findings, results of selected blood tests, and the clinical syndrome and illness severity classifications were compared between four common pathogen groups.
Results: The etiologies of ARinf in this cohort were: rhinovirus = 34(29%), influenza = 17(15%), SARS-CoV-2 = 15(13%), common coronavirus = 13(11%), 'unidentified' = 16(14%), 'dual pathogen' = 9(8%), and 'other' = 12(10%). Clinical presentation differed among the four common pathogen groups as follows: Influenza had more total symptoms, lower respiratory & regional symptoms, and systemic & non-respiratory symptoms than rhinovirus (p ≤ 0.002) and common coronavirus (p < 0.05). Influenza and SARS-CoV-2 had higher total symptoms and systemic & non-respiratory symptom severity scores than rhinovirus (p ≤ 0.0006 and p < 0.03 respectively) and common coronavirus (p ≤ 0.03 and p = 0.02 respectively). Evidence of other non-respiratory organ involvement on clinical examination was highest for influenza (53%). Illness classification for pathogen groups differed: common coronavirus had the highest percentage (%) of rhinitis-like ('common cold') illnesses (69%), and influenza had the highest % of 'flu-like' illnesses (82%). Influenza had the highest % of severe illnesses (88%) and common coronavirus the lowest (31%). 41% of rhinovirus presented with severe illness.
Conclusion: Influenza and SARS-CoV-2 had greater number and severity of symptoms than rhinovirus and common coronavirus. Among the four common pathogen groups, influenza had the highest percentage of abnormal clinical examination and serological findings and severe illnesses. Knowledge of the causative pathogen and the clinical presentation may add value to the risk assessment and guide clinical decision-making in return-to-sport following ARinf in athletic individuals.
期刊介绍:
The Physician and Sportsmedicine is a peer-reviewed, clinically oriented publication for primary care physicians. We examine the latest drug discoveries to advance treatment and recovery, and take into account the medical aspects of exercise therapy for a given condition. We cover the latest primary care-focused treatments serving the needs of our active patient population, and assess the limits these treatments govern in stabilization and recovery.
The Physician and Sportsmedicine is a peer-to-peer method of communicating the latest research to aid primary care physicians’ advancement in methods of care and treatment. We routinely cover such topics as: managing chronic disease, surgical techniques in preventing and managing injuries, the latest advancements in treatments for helping patients lose weight, and related exercise and nutrition topics that can impact the patient during recovery and modification.